CMTP / ICER Hepatitis C Drugs

July 7, 2014

Evidence to Demonstrate Effectiveness & Value | Webinar Panelist

This 90 minute web conference will encourage discussion among stakeholders about the clinical and economic evidence generated for regulatory approval, what additional evidence, if any, would be informative for post-approval decision makers (payers, patients, guideline developers, and policymakers), and strategies to efficiently generate the additional evidence.  The discussion will also address evidence generation for hepatitis C drugs that are expected to receive FDA approval later this year.

Watch the web conference here: http://youtu.be/uYt86EP-Iyg